Abstract:Understanding the etiology of metastasis is very important in clinical perspective, since it is estimated that metastasis accounts for 90% of cancer patient mortality. Metastasis results from a sequence of multiple steps including invasion and migration. The early stages of metastasis are tightly controlled in normal cells and can be drastically affected by malignant mutations; therefore, they might constitute the principal determinants of the overall metastatic rate even if the later stages take long to occur. To elucidate the role of individual mutations or their combinations affecting the metastatic development, a logical model has been constructed that recapitulates published experimental results of known gene perturbations on local invasion and migration processes, and predict the effect of not yet experimentally assessed mutations. The model has been validated using experimental data on transcriptome dynamics following TGF-β-dependent induction of Epithelial to Mesenchymal Transition in lung cancer cell lines. A method to associate gene expression profiles with different stable state solutions of the logical model has been developed for that purpose. In addition, we have systematically predicted alleviating (masking) and synergistic pairwise genetic interactions between the genes composing the model with respect to the probability of acquiring the metastatic phenotype. We focused on several unexpected synergistic genetic interactions leading to theoretically very high metastasis probability. Among them, the synergistic combination of Notch overexpression and p53 deletion shows one of the strongest effects, which is in agreement with a recent published experiment in a mouse model of gut cancer. The mathematical model can recapitulate experimental mutations in both cell line and mouse models. Furthermore, the model predicts new gene perturbations that affect the early steps of metastasis underlying potential intervention points for innovative therapeutic strategies in oncology.

Mathematical Modeling of Metabolism and Hemodynamics

Mathematical modeling of glioma invasion and therapy approaches via kinetic theory of active particles

Mathematical Modelling of a Brain Tumour Initiation and Early Development: A Coupled Model of Glioblastoma Growth, Pre-Existing Vessel Co-Option, Angiogenesis and Blood Perfusion

Mathematical Modeling of the Function of Warburg Effect in Tumor Microenvironment

Modeling of Tumor Growth with Input from Patient-Specific Metabolomic Data

Cell death and life in cancer: mathematical modeling of cell fate decisions

Mathematical Modelling of Molecular Pathways Enabling Tumour Cell Invasion and Migration

Mathematical model of brain tumour growth with drug resistance

Hypoxic Cell Waves Around Necrotic Cores in Glioblastoma: A Biomathematical Model and Its Therapeutic Implications

Mathematical and numerical analysis of a model for anti-angiogenic therapy in metastatic cancers

Modelling glioblastoma resistance to temozolomide. A mathematical model to simulate cellular adaptation in vitro

Data-driven spatio-temporal modelling of glioblastoma

Mathematical Modeling and Analysis of Tumor Chemotherapy

Reaction-Diffusion Models for Glioma Tumor Growth

Mathematical Modelling of Glioblastomas Invasion within the Brain: A 3D Multi-Scale Moving-Boundary Approach

Modeling glioma invasion with anisotropy- and hypoxia-triggered motility enhancement: From subcellular dynamics to macroscopic PDEs with multiple taxis

Mathematical modeling of brain tumors: effects of radiotherapy and chemotherapy

Evolutionary dynamics of glucose-deprived cancer cells: insights from experimentally-informed mathematical modelling

A revised mathematical model of pre-diagnostic glioma growth incorporating vascularization and tumor mutational burden

Mathematical Model of the Impact of Chemotherapy and Anti-Angiogenic Therapy on Drug Resistance in Glioma Growth

Mathematical Analysis of a Model of a Vascular Tumor with Chemotherapy